Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats

Por Tallarida, Christopher S., Tallarida, Ronald J., Rawls, Scott M.
Publicado no Drug Alcohol Depend (2015)

Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians

Por Zhang, Charlie, Tallarida, Christopher S., Raffa, Robert B., Rawls, Scott M.
Publicado em 2013

Predator odor produces anxiety-like behavioral phenotype in planarians that is counteracted by fluoxetine

Por Cho, M, Nayak, Sunil, Jennings, T, Tallarida, Christopher S., Rawls, Scott M.
Publicado no Physiol Behav (2019)

Topiramate antagonism of L-glutamate-induced paroxysms in planarians

Por Raffa, Robert B., Finno, Kristin E., Tallarida, Christopher S., Rawls, Scott M.
Publicado em 2010

Mephedrone interactions with cocaine: prior exposure to ‘bath salt’ constituent enhances cocaine-induced locomotor activation in rats

Por Gregg, Ryan A., Tallarida, Christopher S., Reitz, Allen B., Rawls, Scott M.
Publicado no Behav Pharmacol (2013)

Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats

Por Gregg, Ryan A., Tallarida, Christopher S., Reitz, Allen, McCurdy, Christopher, Rawls, Scott M.
Publicado em 2013

Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice

Por Tallarida, Christopher S., Corley, Gladys, Kovalevich, Jane, Yen, William, Langford, Dianne, Rawls, Scott M.
Publicado em 2013

Ethanol and cocaine: environmental place conditioning, stereotypy and synergism in planarians

Por Tallarida, Christopher S., Bires, Kristopher, Avershal, Jacob, Tallarida, Ronald J., Seo, Stephanie, Rawls, Scott M.
Publicado no Alcohol (2014)

Mu opioid receptor agonist DAMGO produces place conditioning, abstinence-induced withdrawal, and naltrexone-dependent locomotor activation in planarians

Por Dziedowiec, Emily, Nayak, Sunil U., Gruver, Keenan S., Jennings, Tyra, Tallarida, Christopher S., Rawls, Scott M.
Publicado no Neuroscience (2018)

Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo

Por Tallarida, Christopher S., Egan, Erin, Alejo, Gissel D., Raffa, Robert, Tallarida, Ronald J., Rawls, Scott M.
Publicado em 2014

Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians

Por Nayak, Sunil, Roberts, Adam, Bires, Kristofer, Tallarida, Christopher S., Kim, Erin, Wu, Michael, Rawls, Scott M.
Publicado no Behav Pharmacol (2016)

Behavioral effects of Splenda, Equal and sucrose: clues from planarians on sweeteners

Por Ouyang, Kevin, Nayak, Sunil, Lee, Young, Kim, Erin, Wu, Michael, Tallarida, Christopher S., Rawls, Scott M.
Publicado no Neurosci Lett (2016)

Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism

Por Foss, Jeffery D., Nayak, Sunil U., Tallarida, Christopher S., Farkas, Daniel J., Ward, Sara J., Rawls, Scott M.
Publicado no Drug Alcohol Depend (2020)

Nicotine behavioral pharmacology: clues from planarians

Por Rawls, Scott M., Patil, Tanvi, Tallarida, Christopher S., Baron, Steven, Kim, Myongji, Song, Kevin, Ward, Sara, Raffa, Robert B.
Publicado em 2011

PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects

Por Zewde, Ashenafi Mebratu, Yu, Frances, Nayak, Sunil, Tallarida, Christopher, Reitz, Allen B., Kirby, Lynn G., Rawls, Scott M.
Publicado no J Neurosci Methods (2017)

Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator

Por Gregg, Ryan A., Hicks, Callum, Nayak, Sunil U., Tallarida, Christopher S., Nucero, Paul, Reitz, Allen B., Smith, Garry R., Rawls, Scott M.
Publicado no Neuropharmacology (2016)

Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens

Por Gentile, Taylor A., Simmons, Steven J., Tallarida, Christopher S., Su, Shu, Rom, Slava, Watson, Mia N., Reitz, Allen B., Potula, Raghava, Rawls, Scott M.
Publicado no Drug Alcohol Depend (2019)

Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management

Por Eisenstein, Toby K, Chen, Xiaohong, Inan, Saadet, Meissler, Joseph J, Tallarida, Christopher S, Geller, Ellen B, Rawls, Scott M, Cowan, Alan, Adler, Martin W
Publicado no Mil Med (2020)

Adolescent Traumatic Brain Injury Induces Chronic Mesolimbic Neuroinflammation with Concurrent Enhancement in the Rewarding Effects of Cocaine in Mice during Adulthood

Por Merkel, Steven F., Razmpour, Roshanak, Lutton, Evan M., Tallarida, Christopher S., Heldt, Nathan A., Cannella, Lee Anne, Persidsky, Yuri, Rawls, Scott M., Ramirez, Servio H.
Publicado no J Neurotrauma (2017)

Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)

Por Hicks, Callum, Gregg, Ryan A., Nayak, Sunil U., Cannella, Lee Anne, Schena, Giana J., Tallarida, Christopher S., Reitz, Allen B., Smith, Garry R., Rawls, Scott M.
Publicado no Psychopharmacology (Berl) (2017)